In
October of 1982,Tylenol was the leading pain-killer medicine in the United States at the time, faced
a tremendous crisis when seven people in Chicago were reported dead after
taking extra-strength Tylenol capsules. It was reported that an unknown
suspect/s put 65 milligrams of deadly cyanide into Tylenol capsules, 10,000
more than what is necessary to kill a human.The tampering
occurred once the product reached the shelves. They were removed from
the shelves, infected with cyanide and returned to the shelves . In 1982, Tylenol controlled 37 percent of its market with revenue
of about $1.2 million. Immediately after the cyanide poisonings, its market
share was reduced to seven percent. http://iml.jou.ufl.edu/projects/fall02/susi/tylenol.htm Tylenol was headed back to the market, this
time in tamper-proof packaging and bolstered by an extensive media
campaign. A year later, its share of the $1.2 billion analgesic market,
which had plunged to 7 percent from 37 percent following the poisoning,
had climbed back to 30 percent.What set apart Johnson & Johnson's handling of
the crisis from others? It placed consumers first by recalling 31
million bottles of Tylenol capsules from store shelves and offering
replacement product in the safer tablet form free of charge. http://www.nytimes.com/2002/03/23/your-money/23iht-mjj_ed3_.html Johnson & Johnson chairman, James Burke, reacted to the negative media
coverage by forming a seven-member strategy team. The team's strategy
guidance from Burke was first, "How do we protect the people?"
and second "How do we save this product?" The company's first
actions were to immediately alerted consumers across the nation, via the
media, not to consume any type of Tylenol product. They told consumers
not to resume using the product until the extent of the tampering could
be determined. Johnson & Johnson, along with stopping the production
and advertising of Tylenol, withdraw all Tylenol capsules from the store
shelves in Chicago and the surrounding area. After finding 2 more contaminated
bottles Tylenol realized the vulnerability of the product and ordered
a national withdraw of every capsule. By withdrawing all Tylenol, even though there was little chance of discovering
more cyanide laced tablets; Johnson & Johnson showed that they were
not willing to take a risk with the public's safety, even if it cost the
company millions of dollars. The end result was the public viewing Tylenol
as the unfortunate victim of a malicious crime. http://www.ou.edu/deptcomm/dodjcc/groups/02C2/Johnson%20&%20Johnson.htm
No comments:
Post a Comment